Literature DB >> 1361114

Interaction between neurotensin and dopamine in the brain. Morphofunctional and clinical evidence.

W Rostène1, A Brouard, C Dana, Y Masuo, F Agid, M Vial, A M Lhiaubet, D Pelaprat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1361114     DOI： 10.1111/j.1749-6632.1992.tb27352.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  12 in total

1.  Different interactions of prolyl oligopeptidase and neurotensin in dopaminergic function of the rat nigrostriatal and mesolimbic pathways.

Authors:  I Peltonen; T T Myöhänen; P T Männistö
Journal:  Neurochem Res       Date:  2012-06-23       Impact factor: 3.996

Review 2.  Neurotensin agonists: potential in the treatment of schizophrenia.

Authors:  Mona Boules; Amanda Shaw; Paul Fredrickson; Elliott Richelson
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

3.  Antagonism by SR 48692 of mechanical responses to neurotensin in rat intestine.

Authors:  F Mulè; R Serio; A Postorino; T Vetri; F Bonvissuto
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

4.  Allosteric inhibition of the neuropeptidase neurolysin.

Authors:  Christina S Hines; Kallol Ray; Jack J Schmidt; Fei Xiong; Rolf W Feenstra; Mia Pras-Raves; Jan Peter de Moes; Jos H M Lange; Manana Melikishvili; Michael G Fried; Paul Mortenson; Michael Charlton; Yogendra Patel; Stephen M Courtney; Chris G Kruse; David W Rodgers
Journal:  J Biol Chem       Date:  2014-11-05       Impact factor: 5.157

5.  Characterization and distribution of binding sites for a new neurotensin receptor antagonist ligand, [3H]SR 48692, in the guinea pig brain.

Authors:  C Betancur; M Canton; D Gully; G Vela; D Pélaprat; W Rostène
Journal:  J Pharmacol Exp Ther       Date:  1995-06       Impact factor: 4.030

6.  Glycosylated neurotensin analogues exhibit sub-picomolar anticonvulsant potency in a pharmacoresistant model of epilepsy.

Authors:  Hee-Kyoung Lee; Liuyin Zhang; Misty D Smith; H Steve White; Grzegorz Bulaj
Journal:  ChemMedChem       Date:  2009-03       Impact factor: 3.466

7.  Steroid effects on brain functions: an example of the action of glucocorticoids on central dopaminergic and neurotensinergic systems.

Authors:  W Rostène; A Sarrieau; A Nicot; V Scarceriaux; C Betancur; D Gully; M Meaney; W Rowe; R De Kloet; D Pelaprat
Journal:  J Psychiatry Neurosci       Date:  1995-11       Impact factor: 6.186

8.  Treatment of PC12 cells by nerve growth factor, dexamethasone, and forskolin. Effects on cell morphology and expression of neurotensin and tyrosine hydroxylase.

Authors:  T Caillaud; W Y Opstal; V Scarceriaux; C Billardon; W Rostene
Journal:  Mol Neurobiol       Date:  1995 Apr-Jun       Impact factor: 5.590

9.  Immunological recognition of different forms of the neurotensin receptor in transfected cells and rat brain.

Authors:  H Boudin; A Grauz-Guyon; M P Faure; P Forgez; A M Lhiaubet; M Dennis; A Beaudet; W Rostene; D Pelaprat
Journal:  Biochem J       Date:  1995-01-01       Impact factor: 3.857

10.  Presynaptic action of neurotensin on dopamine release through inhibition of D(2) receptor function.

Authors:  Charbel S Fawaz; Philippe Martel; Damiana Leo; Louis-Eric Trudeau
Journal:  BMC Neurosci       Date:  2009-08-14       Impact factor: 3.288
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.